- Home
- BTM vs BYSI Comparison
BTM vs BYSI Comparison
Compare BTM & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.50
Company Overview
Basic Information| Metric | BTM | BYSI |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.8M | 79.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | BTM | BYSI |
|---|---|---|
| Price | $1.08 | $1.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 890.6K | 52.4K |
| Earning Date | 03-17-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $635,643,000.00 | N/A |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.10 | ★ N/A |
| Revenue Growth | ★ 8.61 | N/A |
| 52 Week Low | $0.93 | $0.98 |
| 52 Week High | $6.88 | $3.44 |
Technical Indicators
Market Signals| Indicator | BTM | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 38.51 |
| Support Level | $1.16 | $1.51 |
| Resistance Level | $1.44 | $1.66 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 10.54 | 11.11 |
Price Performance
Historical Comparison BTM
BYSI
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.